Cite
Kwak MS, Kim KJ, Cheon JH, et al. Comparison of Concomitant Mesalamine and Immunomodulator Therapy and Immunomodulator Monotherapy for Crohn's Disease. Gastroenterol Res Pract. 2018;2018:4826973doi: 10.1155/2018/4826973.
Kwak, M. S., Kim, K. J., Cheon, J. H., Kim, W. S., Lee, J. M., Hwang, S. W., Park, S. H., Yang, D. H., Ye, B. D., Byeon, J. S., Myung, S. J., & Yang, S. K. (2018). Comparison of Concomitant Mesalamine and Immunomodulator Therapy and Immunomodulator Monotherapy for Crohn's Disease. Gastroenterology research and practice, 20184826973. https://doi.org/10.1155/2018/4826973
Kwak, Min Seob, et al. "Comparison of Concomitant Mesalamine and Immunomodulator Therapy and Immunomodulator Monotherapy for Crohn's Disease." Gastroenterology research and practice vol. 2018 (2018): 4826973. doi: https://doi.org/10.1155/2018/4826973
Kwak MS, Kim KJ, Cheon JH, Kim WS, Lee JM, Hwang SW, Park SH, Yang DH, Ye BD, Byeon JS, Myung SJ, Yang SK. Comparison of Concomitant Mesalamine and Immunomodulator Therapy and Immunomodulator Monotherapy for Crohn's Disease. Gastroenterol Res Pract. 2018 Jan 18;2018:4826973. doi: 10.1155/2018/4826973. eCollection 2018. PMID: 29576767; PMCID: PMC5822780.
Copy
Download .nbib